(600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Capital Increase in Investee Company and Related Party Transactions
Filed with SSE · Stock code 600521 · · 9 pages · Chinese
Summary by 6ix AI
Zhejiang Huahai Pharmaceutical Co., Ltd. announced a capital increase in its investee company, Huahai Tianheng (Shanghai) Pharmaceutical Research Co., Ltd., along with related party transactions. The company plans to invest approximately a specified amount in Huahai Tianheng, maintaining its ownership percentage post-investment. This transaction is classified as a related party transaction but does not constitute a major asset restructuring. The board has approved the transaction, which does not require shareholder approval and is not expected to adversely affect the company's operations.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Zhejiang Huahai Pharmaceutical Co., Ltd. on 6ix
Story so far
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Conversion Results of Convertible Corporate Bonds and Share Changes
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Estimated Increase in Performance for the First Three Quarters of 2026
- Announcement on Progress in Providing Guarantee for Subsidiary
Earlier from Zhejiang Huahai Pharmaceutical
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Conversion Results of Convertible Corporate Bonds and Share Changes
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Estimated Increase in Performance for the First Three Quarters of 2026
- Announcement on Progress in Providing Guarantee for Subsidiary
- Third Indicative Announcement on Redemption at Maturity and Delisting of "HUAHAI Convertible Bonds"
- Second Indicative Announcement on Maturity Redemption and Delisting of "HUAHAI Convertible Bonds"
Later from Zhejiang Huahai Pharmaceutical
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Capital Increase and Share Expansion of Controlled Subsidiary for Introduction of Investors
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Resolutions of the 17th Extraordinary Meeting of the 9th Board of Directors
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Obtaining Drug Registration Certificate
- (600521)"ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD."Announcement on Redemption at Maturity and Delisting of "HUAHAI Convertible Bonds"
Follow Zhejiang Huahai Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huahai Pharmaceutical